Post job

Denali Therapeutics overview

Industry
Biotechnology
Revenue
Headquarters
Employees
291
Founded in
Website
Organization type
Public
Social media
Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development.
Denali Therapeutics is a medium health care company with 291 employees and an annual revenue of $330.5M that is headquartered in San Francisco, CA.

Denali Therapeutics's mission statement

Denali therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development.

In demand companies are hiring! Let Zippi apply for you!

Floating question marks illustration
-

Denali Therapeutics employee reviews

Be the first to review!

Do you work at Denali Therapeutics?

Help job seekers learn about working at Denali Therapeutics

Job openings at Denali Therapeutics
30 positions

On this page

Be the first to review Denali Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Denali Therapeutics?

The team at Denali Therapeutics

  • The founders of Denali Therapeutics are Ryan J. Watts, Marc Tessier-Lavigne and Alexander O. Schuth.
  • The key people at Denali Therapeutics are Ryan J. Watts, Marc Tessier-Lavigne and Alexander O. Schuth.
Key people
Ryan J. Watts
Marc Tessier-Lavigne
Alexander O. Schuth

Denali Therapeutics salaries

Average Denali Therapeutics salary
$94,893
yearly
$45.62 hourly
Updated March 14, 2024

Rate Denali Therapeutics' promotion and raise policies.

Zippia waving zebra

Do you work at Denali Therapeutics?

Does Denali Therapeutics actively promote diversity and inclusion?

Denali Therapeutics financial performance

9.8
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Denali Therapeutics currently has 108.5M in revenue. Denali Therapeutics's most recent quarter produced 294.1m (q2'2023).

Denali Therapeutics annual revenue

$336M
$269M
$201M
$134M
$67M
$0
2018
2019
2020
2021
2022
2023

Are you an executive, HR leader, or brand manager at Denali Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Denali Therapeutics FAQs

Search for jobs

Most common locations at Denali Therapeutics

Zippia gives an in-depth look into the details of Denali Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Denali Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Denali Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Denali Therapeutics. The data presented on this page does not represent the view of Denali Therapeutics and its employees or that of Zippia.

Denali Therapeutics may also be known as or be related to DENALI THERAPEUTICS INC., Denali Therapeutics, Denali Therapeutics Inc and Denali Therapeutics Inc.